Traders cheered Aurobindo's in-line performance by sending the stock nearly 4 percent higher. But they punished Sun Pharma for missing Street estimates across the board by sending the stock down over 6 percent. CNBC-TV18's Ekta Batra and Archana Shukla crunch the numbers.
Two pharma companies, but different stories. That's the picture Sun Pharma and Aurobindo Pharma's quarterly numbers have painted.
And the reaction from the Street has been fitting.
Traders cheered Aurobindo's in-line performance by sending the stock nearly 4 percent higher. But they punished Sun Pharma for missing Street estimates across the board by sending the stock down over 6 percent.
CNBC-TV18's Ekta Batra and Archana Shukla crunch the numbers.
Watch the video for more
Subscribe to Moneycontrol Pro's Annual plan for Rs 399/- for the first year. Use coupon PRO2020 (Available on Web & Android only).
First Published on May 31, 2016 09:54 pm
